Beta-Thalassemia Clinical Trials in Tianjin, Tianjin Municipality
4 recruitingTianjin, Tianjin Municipality, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Not Applicable
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
Transfusion Dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China3 enrolled1 locationNCT06219239
Recruiting
Phase 1Phase 2
Β-Thalassemia Treatment with KL003 Cell Injection
Transfusion Dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd.41 enrolled2 locationsNCT06280378
Recruiting
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
Gene TherapyTransfusion Dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China100 enrolled1 locationNCT05991336